Trial Summary
What is the purpose of this trial?This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women and supplemental telephone-based Health Coaching for women who miss their appointment.
What safety data exists for the HERS Program for Cervical Cancer?The provided research does not contain specific safety data for the HERS Program for Cervical Cancer. The studies mentioned focus on the CHESS system for breast cancer, which is a different program. No direct safety data for HERS is available in the given research.134911
Is the Health Enhancement Resource System (HERS) a promising treatment for cervical cancer?The Health Enhancement Resource System (HERS) is a promising treatment for cervical cancer because it focuses on increasing awareness and encouraging positive health behaviors, especially among women who might not have easy access to healthcare. By empowering communities and improving access to screening and follow-up care, HERS aims to reduce the rates of cervical cancer, making it a valuable approach in preventing and managing the disease.2781012
What data supports the idea that HERS Program for Cervical Cancer is an effective treatment?The available research does not provide specific data or evidence supporting the effectiveness of the HERS Program for Cervical Cancer. The articles focus on general health information systems and outcomes research but do not mention the HERS Program or its impact on cervical cancer treatment. Therefore, there is no direct comparison or data available to show its effectiveness compared to other treatments for cervical cancer.56131415
Do I need to stop my current medications for this trial?The trial protocol does not specify whether you need to stop taking your current medications.
Eligibility Criteria
This trial is for women who have had abnormal cervical cancer screening results. It's designed to help them follow up on their care using text messages and phone calls. Women must be able to receive texts and calls, but can't join if they are already following a similar program or have conditions that interfere with study participation.Exclusion Criteria
I have or had cervical cancer.
Treatment Details
The trial tests the Health Enhancement Resource System (HERS), which uses texts and health coaching calls to encourage women to follow up after an abnormal cervical screening result. The effectiveness of HERS at different stages (1-4) with or without Health Coaching (HC) compared to standard care is being studied.
13Treatment groups
Experimental Treatment
Group I: Stage, 2, and 3 HERS + Stage 4 HERS+HCExperimental Treatment4 Interventions
Start with Stage 1 HERS intervention; patient does not attend baseline colposcopy appointment, continue with Stage 2 HERS intervention. Continue with Stage 3 HERS intervention; patient does not attend 12-month follow-up appointment, continue with Stage 4 HERS+HC intervention.
Group II: Stage 1, 3, and 4 HERSExperimental Treatment3 Interventions
Start with Stage 1 HERS intervention; patient attends baseline colposcopy appointment, no Stage 2 intervention. Continue with Stage 3 HERS intervention; patient does not attend 12-month follow-up appointment, continue with Stage 4 HERS intervention.
Group III: Stage 1, 2, and 3 HERSExperimental Treatment3 Interventions
Start with Stage 1 HERS intervention; patient does not attend baseline colposcopy appointment, continue with Stage 2 HERS intervention. Continue with Stage 3 HERS intervention; patient attends 12-month follow-up appointment, no Stage 4 intervention.
Group IV: Stage 1, 2, 3, and 4 HERSExperimental Treatment4 Interventions
Start with Stage 1 HERS intervention; patient does not attend baseline colposcopy appointment, continue with Stage 2 HERS intervention. Continue with Stage 3 HERS intervention; patient does not attend 12-month follow-up appointment, continue with Stage 4 HERS intervention.
Group V: Stage 1 and 3 SoC + Stage 4 HERSExperimental Treatment3 Interventions
Start with Stage 1 Standard of Care; patient attends baseline colposcopy appointment, no Stage 2 intervention. Continue with Stage 3 Standard of Care; patient does not attend 12-month follow-up appointment, continue with Stage 4 HERS intervention.
Group VI: Stage 1 and 3 SoCExperimental Treatment2 Interventions
Start with Stage 1 Standard of Care; patient attends baseline colposcopy appointment, no Stage 2 intervention. Continue with Stage 3 Standard of Care; patient attends 12-month follow-up appointment, no Stage 4 intervention.
Group VII: Stage 1 and 3 HERS + Stage 4 HERS+HCExperimental Treatment3 Interventions
Start with Stage 1 HERS intervention; patient attends baseline colposcopy appointment, no Stage 2 intervention. Continue with Stage 3 HERS intervention; patient does not attend 12-month follow-up appointment, continue with Stage 4 HERS+HC intervention.
Group VIII: Stage 1 and 3 HERSExperimental Treatment2 Interventions
Start with Stage 1 HERS intervention; patient attends baseline colposcopy appointment, no Stage 2 intervention. Continue with Stage 3 HERS intervention; patient attends 12-month follow-up appointment, no Stage 4 intervention.
Group IX: Stage 1 SoC + Stage 2, 3, and 4 HERSExperimental Treatment4 Interventions
Start with Stage 1 Standard of Care; patient does not attend baseline colposcopy appointment, continue with Stage 2 HERS intervention. Continue with Stage 3 HERS intervention; patient does not attend 12-month follow-up appointment, continue with Stage 4 HERS intervention.
Group X: Stage 1 SoC + Stage 2 and 3 HERS + Stage 4 HERS+HCExperimental Treatment4 Interventions
Start with Stage 1 Standard of Care; patient does not attend baseline colposcopy appointment, continue with Stage 2 HERS intervention. Continue with Stage 3 HERS intervention; patient does not attend 12-month follow-up appointment, continue with Stage 4 HERS+HC intervention.
Group XI: Stage 1 SoC + Stage 2 and 3 HERSExperimental Treatment3 Interventions
Start with Stage 1 Standard of Care; patient does not attend baseline colposcopy appointment, continue with Stage 2 HERS intervention. Continue with Stage 3 HERS intervention; patient attends 12-month follow-up appointment, no Stage 4 intervention.
Group XII: Stage 1 HERS + Stage 2, 3, and 4 HERS+HCExperimental Treatment4 Interventions
Start with Stage 1 HERS intervention, patient does not attend baseline colposcopy appointment, continue with Stage 2 HERS+HC intervention. Continue with Stage 3 HERS+HC intervention; patient does not attend 12-month follow-up appointment, continue with Stage 4 HERS+HC intervention.
Group XIII: Stage 1 HERS + Stage 2 and 3 HERS+HCExperimental Treatment3 Interventions
Start with Stage 1 HERS intervention, patient does not attend baseline colposcopy appointment, continue with Stage 2 HERS+HC intervention. Continue with Stage 3 HERS+HC intervention; patient attends 12-month follow-up appointment, no Stage 4 intervention.
Find a clinic near you
Research locations nearbySelect from list below to view details:
Rutgers, The State University of New JerseyNew Brunswick, NJ
Thomas Jefferson UniversityPhiladelphia, PA
Fox Chase Cancer CenterPhiladelphia, PA
Loading ...
Who is running the clinical trial?
Fox Chase Cancer CenterLead Sponsor
Rutgers, The State University of New JerseyCollaborator
Temple UniversityCollaborator
University of South CarolinaCollaborator
Thomas Jefferson UniversityCollaborator
References
CHESS: An interactive computer system for women with breast cancer piloted with an under-served population. [2022]The Comprehensive Health Enhancement Support System (CHESS) is an interactive computer system containing information, social support and problem solving tools. It was developed with intensive input from potential users through needs-assessment surveys and field testing. CHESS had previously been used by women in the middle and upper socio-economic classes with high school and college education. This article reports on the results of a pilot study involving eight African-American women with breast cancer from impoverished neighborhoods in the city of Chicago. CHESS was very well received, extensively used and produced feelings of acceptance, motivation, understanding and relief.
Cervical cancer prevention project for inner city black and Latina women. [2022]Early detection, appropriate intervention, and adequate followup treatment make cervical cancer one of the most preventable of all diseases. The authors propose a project designed to increase knowledge and awareness of cervical cancer and its prevention and ultimately to decrease morbidity and mortality rates for cervical cancer in black and Latino inner-city communities of Boston. During a 3-year project the authors hope to reach about 500 high-risk women who currently do not have access to health care services. The interventions would be based in the Boston, MA, community areas of Roxbury and Jamaica Plain, specifically in those neighborhoods served by a designated community health center. High rates of cervical cancer are found in inner-city communities, where black and Latina women usually are overrepresented. About 80 percent of the women served by the designated community health center are either black or Latina. The proposed intervention has three objectives: (a) to increase the use of health services by so-called hard-to-reach women in those communities; (b) to reduce the numbers of women who, after learning of their abnormal Papanicolaou test results, do not return for followup; and (c) to increase sensitivities toward the problem and to encourage participation in such a project among health care providers at the community health center.
CHESS: comprehensive health enhancement support system for women with breast cancer. [2007]The Comprehensive Health Enhancement Support System (CHESS) was developed to assist people dealing with health crises. Needs assessments with patients were conducted in its development and validation studies performed. CHESS provides information, social support, and decision-making assistance via a personal computer and modem that are placed in patients' homes. Women of all ages and varied socioeconomic backgrounds have successfully used this program to empower them to become active participants in their care following a diagnosis of breast cancer.
CHESS (Comprehensive Health Enhancement Support System): an interactive computer system for women with breast cancer piloted with an underserved population. [2019]The Comprehensive Health Enhancement Support System (CHESS) is an interactive computer system containing information, social support, and problem-solving tools. It was developed with intensive input from potential users through needs-assessment surveys and field testing. CHESS had previously been used by women in the middle and upper socioeconomic classes with high school and college education. This article reports on the results of a pilot study involving eight African-American women with breast cancer from impoverished neighborhoods in Chicago. CHESS was very well received; was extensively used; and produced feelings of acceptance, motivation, understanding, and relief.
Clinical practice evaluation at Providence Health System. [2019]Over the past seven years, Providence Health System (PHS) in Portland, Oregon, has used an outcomes research paradigm to study treatment of back pain, coronary artery disease, total joint replacement, and cancer. In presenting case studies of each of these areas, the authors chronicle the evolution of clinical practice evaluation at PHS, beginning with early studies in the 1960s, to the establishment of the Center for Outcomes Research and Education (CORE), to the formation of a new systemwide strategy that is responsive to the evolving health care marketplace.
Using HIS data for health care research. [2019]The importance of measuring healthcare performance and outcome rapidly grows around the world. As hospital information systems (HIS) become more commonplace, their use as clinical research tools can be easily developed. This is demonstrated in the article by two examples of clinical outcomes research undertaken on the world's largest HIS database. The research studies described in the article were on: (1) The effect of hospital 'experience' on inpatient mortality rates for patients with HIV-related pneumocystis carinii pneumonia, and (2) The effect of streptokinase and tPA on post-acute myocardial infarction survival rates.
A community capacity-enhancement approach to breast and cervical cancer screening among older women of color. [2022]In the Screening Older Minority Women project, the authors applied a community capacity-enhancement approach to promoting breast and cervical cancer screening among older women of color. Members of informal support networks were recruited for this health promotion intervention to empower Latina and African American women to engage in positive health behaviors. The authors describe the phases of the intervention and the experiences from the community. Guidelines are identified to help researchers and practitioners in planning and implementing community health promotion intervention with women of color.
Evidence-based intervention to reduce access barriers to cervical cancer screening among underserved Chinese American women. [2022]The primary objective of the present study was to evaluate the effects of a community-based pilot intervention that combined cervical cancer education with patient navigation on cervical cancer screening behaviors among Chinese American women residing in New York City.
Radiation Oncology Safety Information System (ROSIS)--profiles of participants and the first 1074 incident reports. [2022]The Radiation Oncology Safety Information System (ROSIS) was established in 2001. The aim of ROSIS is to collate and share information on incidents and near-incidents in radiotherapy, and to learn from these incidents in the context of departmental infrastructure and procedures.
Using intervention mapping as a participatory strategy: development of a cervical cancer screening intervention for Hispanic women. [2021]Cervical cancer is preventable with treatment of precancerous lesions and treatable at early stages. Hispanics have higher rates of cervical cancer and lower rates of screening. Ayudando a las Mujeres con Informacción, Guía, y Amor para su Salud (AMIGAS) is an intervention to increase cervical cancer screening in U.S. women of Mexican origin. AMIGAS was developed with the participation of the community using intervention mapping (IM). Following the IM process, the authors completed a needs assessment, development of program objectives, selection of intervention methods and strategies, and program design. A benefit of IM is its linkage with community-based participatory research as it includes engagement of community members to identify and refine priority areas. The success of this strategy suggests it a useful tool for other populations. The resulting intervention program is currently being tested for efficacy and cost-effectiveness in three sites: El Paso, Texas; Houston, Texas; and Yakima, Washington.
Improvement of medication event interventions through use of an electronic database. [2019]Patient safety enhancements achieved through the use of an electronic Web-based system for responding to adverse drug events (ADEs) are described.
Public health national approach to reducing breast and cervical cancer disparities. [2021]Breast and cervical cancer have had disparate impact on the lives of women. The burden of breast and cervical cancer is more prominent among some racial and ethnic minority women. Providing comprehensive care to all medically underserved women is a critical element in continuing the battle to reduce cancer burden and eliminate disparities. The National Breast and Cervical Cancer Early Detection Program is the only nationally organized cancer screening program for underserved women in the United States. Its public health goal is to ensure access to high-quality screening, follow-up, and treatment services for diverse and vulnerable populations that, in turn, may reduce disparities.
Utilizing an integrated infrastructure for outcomes research: a systematic review. [2019]To explore the ability of an integrated health information infrastructure to support outcomes research.
"Our lab is the community": Defining essential supporting infrastructure in engagement research. [2022]Effective patient engagement is central to patient-centered outcomes research. A well-designed infrastructure supports and facilitates patient engagement, enabling study development and implementation. We sought to understand infrastructure needs from recipients of Patient-Centered Outcomes Research Institute (PCORI) pilot grant awards.
Standards, Processes, and Tools Used to Evaluate the Quality of Health Information Systems: Systematic Literature Review. [2022]Evaluating health information system (HIS) quality is strategically advantageous for improving the quality of patient care. Nevertheless, few systematic studies have reported what methods, such as standards, processes, and tools, were proposed to evaluate HIS quality.